INO .72 Piper Jaffray chirps in "Overweight" on INO with a $1.00 price target. http://www.streetinsider.com/New+Coverage/Piper+Jaffray+Starts+Inovio+Pharmaceuticals+%28INO%29+at+Overweight/8016998.html And this piece trots out the number "$30 billion" in an INO article: http://moneymorning.com/2013/01/17/meet-the-biotech-ceo-with-a-30-billion-breakthrough/ Excellent ground floor op for those with a 1-2 year investment plan IMO.